2003 turnover for France (for all business, including export):
9.97 billion Euros, up 9.1% from 2002.

2003 Drug sales1

7.5 billion Euros, up 8.2% (+ 4.3% for the sector as a whole).

Non hospital reimbursable drug sale

4.3 billion Euros, up 9.6% from 2002 (+ 6.1% for the sector as a whole).

Hospital drug sales

1.4 billion Euros, up 6.2% from 2002 (+ 10% for the sector as a whole).

Drug export sales

1.6 billion Euros, down 0.4% from 2002 (+ 0.43% for the sector as a whole).

2003 Investment in France

370 million Euros, 6.7% drop

           

AGIPHARM accounted for more than a quarter of all pharmaceutical business in France in 2003.

Breakdown of AGIPHARM member company facilities in France

  • 20 production facilities
  • 16 head offices
  • 10 research and development centres
  • 5 distribution sites

These facilities represent an investment of more than 1.6 billion Euros with forecasted expansion or new construction plans of more than 450 million Euros for the 2003-2009 period.




Employment

AGIPHARM companies employed 22,323 people in 2003, accounting for 22.3% of all pharmaceutical industry jobs in France with annual growth of 1.1%. In 2002, new jobs with AGIPHARM companies were created at a rate 30% higher than the average job creation rate for the sector.

Professional training

Some 45 million Euros were allocated to ongoing professional training in 2003, which represents annual per-employee spending of 2,017 Euros.

Payroll contributions and taxes

One billion Euros for 2003 (10.3% of turnover).